|Bid||2.090 x 100|
|Ask||2.120 x 400|
|Day's Range||2.100 - 2.180|
|52 Week Range||2.020 - 30.000|
|PE Ratio (TTM)||0.11|
|Earnings Date||Nov 27, 2017 - Dec 1, 2017|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||37.00|
COPENHAGEN, Denmark, Feb. 07, 2018-- Forward Pharma A/S today announced that Dr. Claus Bo Svendsen, the Company’ s Chief Executive Officer, will give a corporate update at the 7th Annual Leerink Partners ...
COPENHAGEN, Denmark, Jan. 29, 2018-- Forward Pharma A/S today announced that the European Patent Office has revoked the EP2801355 patent following the oral hearing in the Opposition Proceedings.. The EPO ...
Research Desk Line-up: Forward Pharma Post Earnings Coverage LONDON, UK / ACCESSWIRE / October 9, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for AVEO ...